The burden of acute coronary syndrome: The second leading cause of death in Canada

November 1, 2010

CRA was commissioned by AstraZeneca to investigate the economic and societal burden associated with Acute Coronary Syndrome (ACS) in Canada. This short paper represents a summary of the full report.

Related capabilities

Key contacts